The Effect of Avocado Consumption on Vascular Health
The Influence of Daily Consumption of Avocado on Biomarkers of Vascular Health
1 other identifier
interventional
60
1 country
1
Brief Summary
The study will investigate the effect of avocado consumption on markers of vascular health. Sixty participants will be enrolled in the 6-week study. A randomized parallel design will be utilized. Participants will either receive a typical American diet, or a modified typical American diet in which avocado is substituted for foods that contain moderate and high amounts of saturated fat, to allow the isoenergetic inclusion of avocado.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2012
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 7, 2012
CompletedStudy Start
First participant enrolled
April 1, 2012
CompletedFirst Posted
Study publicly available on registry
May 10, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2012
CompletedFebruary 24, 2016
February 1, 2016
3 months
February 7, 2012
February 23, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Change in Endothelial Function
Noninvasive endothelial function will be assessed, following a 12-hours fast, by measuring endothelium-dependent flow mediated dilation of the peripheral bed. Participants will then consume a test meal and endothelial function will be assessed again 3 hours later.
0 hr and 3 hr at baseline and after 6 weeks
Secondary Outcomes (3)
Change in Blood Pressure
Baseline and after 6 weeks
Change in Gene Expression
Baseline and after 6 weeks
Change in Biomarkers of Cardiovascular Disease Risk
Baseline and after 6 weeks
Study Arms (2)
Typical American Diet
ACTIVE COMPARATORParticipants will receive a typical American diet for 6 weeks.
Avocado Diet
EXPERIMENTALParticipants will receive a modified typical American diet in which avocado is substituted for foods that contain moderate and high amounts of saturated fat to allow the inclusion of avocado.
Interventions
Participants will consume a controlled diet for 6 weeks where all meals will be provided by the facility. Participants will be instructed to eat all foods and only foods provided to them.
Eligibility Criteria
You may qualify if:
- BMI between 25 and 42 kg/m2
- Age 28 to 70 years during the intervention
- Fasting glucose ≤ 126 mg/dl
- Blood pressure ≤ 160/100 mm Hg
You may not qualify if:
- Presence of kidney disease, liver disease, gout, certain cancers, thyroid disease, gastrointestinal, other metabolic diseases, or malabsorption syndromes
- Women who have given birth during the previous 12 months
- Pregnant women or women who plan to become pregnant or become pregnant during the study
- Lactating women
- Type 2 diabetes requiring the use of oral antidiabetic agents or insulin
- History of eating disorders or other dietary patterns which are not consistent with the dietary intervention (e.g., vegetarians, very low fat diets, high protein diets)
- Volunteers who routinely participate in "heavy" exercise or volunteers who initiate an exercise program during the study.
- Volunteers who have lost 10% of body weight within the last 12 months
- Use of prescription or over-the-counter antiobesity medications or supplements (e.g., phenylpropanalamine, ephedrine, caffeine, during and for at least 6 months prior to the start of the study) or history of a surgical intervention for obesity
- Active cardiovascular disease (such as heart attack or procedure within the past three months or participation in a cardiac rehabilitation program within last three months, stroke or history/treatment for transient ischemic attacks in the past three months, or documented history of pulmonary embolus in past six months)
- Smokers or other tobacco users (during the 6 months prior to the start of the study)
- Unable or unwilling to give informed consent or communicate with study staff
- Other medical, psychiatric, or behavioral factors that in the judgment of the Principal Investigator may interfere with study participation or the ability to follow the intervention protocol.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
USDA Beltsville Human Nutrition Research Center
Beltsville, Maryland, 20705, United States
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Physiologist
Study Record Dates
First Submitted
February 7, 2012
First Posted
May 10, 2012
Study Start
April 1, 2012
Primary Completion
July 1, 2012
Study Completion
July 1, 2012
Last Updated
February 24, 2016
Record last verified: 2016-02